M Comaschi

Summary

Affiliation: San Martino University Hospital
Country: Italy

Publications

  1. ncbi Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes
    M Comaschi
    Emergency Department, University Hospital St Martin, Genoa, Italy
    Diabetes Technol Ther 9:387-98. 2007
  2. ncbi The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia
    M Comaschi
    Emergency Department, University Hospital St Martin, Genoa, Italy
    Nutr Metab Cardiovasc Dis 18:373-9. 2008
  3. ncbi Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus
    E Bonora
    Division of Endocrinology and Metabolic Diseases, University Hospital, Piazzale Stefani, 1, 37126, Verona, Italy
    Diabetologia 49:846-54. 2006
  4. ncbi Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management
    G Crepaldi
    Department of Medical and Surgical Sciences, University of Padua, 35128 Padua, Italy
    J Endocrinol Invest 30:610-4. 2007

Detail Information

Publications4

  1. ncbi Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes
    M Comaschi
    Emergency Department, University Hospital St Martin, Genoa, Italy
    Diabetes Technol Ther 9:387-98. 2007
    ....
  2. ncbi The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia
    M Comaschi
    Emergency Department, University Hospital St Martin, Genoa, Italy
    Nutr Metab Cardiovasc Dis 18:373-9. 2008
    ..This paper examines the effectiveness of adding pioglitazone to metformin or a sulphonylurea (SU) compared with a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia in patients with Type 2 diabetes...
  3. ncbi Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus
    E Bonora
    Division of Endocrinology and Metabolic Diseases, University Hospital, Piazzale Stefani, 1, 37126, Verona, Italy
    Diabetologia 49:846-54. 2006
    ....
  4. ncbi Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management
    G Crepaldi
    Department of Medical and Surgical Sciences, University of Padua, 35128 Padua, Italy
    J Endocrinol Invest 30:610-4. 2007
    ..Lastly, they have substantial advantages with respect to other anti-diabetic drugs, since they involve a low risk of hypoglycemia and do not affect body weight...